Table 1 Characterization of patients with A-T
From: Is age a risk factor for liver disease and metabolic alterations in ataxia Telangiectasia patients?
Variable | N (%) | |
|---|---|---|
Age (n = 18) | 5–15 years | 12 (66.6%) |
16–25 years | 6 (33.3%) | |
Nutritional status (n = 18) | Malnutrition | 6 (33.3%) |
Normal body mass index | 11 (61.1%) | |
Overweight | 1 (5.5%) | |
Fat mass (n = 18) | Low | 2 (11.1%) |
Adequate | 9 (50.0%) | |
High | 7 (38.9%) | |
Mid-upper arm muscle circumference (n = 18) | Low | 10 (55.5%) |
Adequate | 8 (44.4%) | |
Lipid profile (n = 18) | High total cholesterol | 10 (55.5%) |
High LDL-c | 10 (55.5%) | |
High triglyceride | 8 (44.4%) | |
Low HDL-c | 10 (55.5%) | |
High NHDL-c | 11 (61.1%) | |
Diabetes mellitus (n = 18) | >200 mg/dL | 1 (5.5%) |
Oral Glucose Tolerance Test (n = 11) | Normal | 5 (45.4%) |
Glucose intolerance | 1 (9.1%) | |
Insulin resistance | 4 (36.4%) | |
Glucose intolerance and Insulin resistance | 1 (9.1%) | |
ALT (n = 17) | > 40 U/L | 7 (41.2%) |
AST/ALT (n = 17) | > 1 | 10 (58.8%) |
Hepatic steatosis (n = 17) | No | 6 (35.3%) |
Mild | 7 (41.2%) | |
Moderate | 4 (23.5%) | |
Liver involvement (n = 17) | 7 (41.2%) |